Cytochrome P-450 CYP2C8 Inducers (weak)
- Name
- Cytochrome P-450 CYP2C8 Inducers (weak)
- Accession Number
- DBCAT003898
- Description
Not Available
- Drugs
Drug Drug Description Rifabutin An antibiotic used to treat mycobacterium avium complex disease in patients with HIV. Dabrafenib A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. Quinidine A medication used to restore normal sinus rhythm, treat atrial fibrillation and flutter, and treat ventricular arrhythmias. Avatrombopag A thrombopoietin receptor agonist used pre-operatively to treat thrombocytopenia in patients with chronic liver disease and in patients with chronic refractory thrombocytopenia. Isavuconazole Indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [FDA Label]. Indicated for patients 18 years of age and older for the treatment of... Tecovirimat An antiviral medication used to treat smallpox, monkeypox, and cowpox. Omaveloxolone A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. - Drugs & Drug Targets